The analysis evidences revealed that the p16 hypermethylation proportion in MM was remarkably higher than that in the normal bone marrow, indicating that the p16 hypermethylation may play a role in the initiation of MM. The gene discussed is CDKN2A; the disease is Miyoshi myopathy.